The future of rotavirus vaccines

Seminars in Pediatric Infectious Diseases

Volumn 13, Issue 3, 2002, Pages 190-195

  Offit, Paul A ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTA TEQ; ROTAVIRUS VACCINE; LIVE VACCINE;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIARRHEA; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; HUMAN; INFECTION PREVENTION; INTUSSUSCEPTION; LICENSING; NONHUMAN; PATHOGENESIS; RISK ASSESSMENT; ROTAVIRUS; VIRUS INFECTION; VIRUS STRAIN; IMMUNOLOGY; INFANT; METHODOLOGY; REVIEW; SAFETY; VACCINATION;

HUMANS; INFANT; LICENSURE; RISK ASSESSMENT; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SAFETY; VACCINATION; VACCINES, ATTENUATED;

EID: 0036628942     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/spid.2002.125862     Document Type: Article

References (49)

1. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children - Recommendations of the Advisory Committee on Immunization Practices
2. Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine
3. Intussusception among recipients of rotavirus vaccine - United States, 1998-1999
4. Possible association of intussusception with rotavirus vaccination
5. Intussusception among infants given an oral rotavirus vaccine
6. Population-based study of rotavirus vaccination and intussusception
7. Withdrawal of rotavirus vaccine recommendation
8. Interventions for the control of diarrhoeal diseases among young children: Rotavirus and cholera immunization
9. Pediatric viral gastroenteritis during eight years of study
10. The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden
11. Trends of diarrheal disease-associated mortality in U.S. children, 1968 through 1991
12. Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children
13. The magnitude of the global problem of diarrhoeal disease: A ten-year update
14. Global mortality, disability, and the contribution of risk factors: Global burden of disease study
15. Selective primary health care: An interim strategy for disease control in developing countries
16. The magnitude of the global problem of acute diarrhoeal disease: A review of active surveillance data
17. Rotavirus gene structure and function
18. Independent segregation of two antigenic specificities (vp3 and vp7) involved in neutralization of rotavirus infectivity
19. Identification of the two rotavirus genes determining neutralization specificities
20. Rotaviruses and their replication
21. Genetic determinants of rotavirus virulence studied in gnotobiotic piglets
22. Rotavirus vp7 neutralization epitopes of serotype 3 strains
23. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children
24. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - Report of the National Multicenter Trial
25. Randomized placebo-controlled trial of rhesus human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis
26. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela
27. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations
28. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection
29. Paediatric intussusception
30. Intussusception among recipients of rotavirus vaccine: Reports to the Vaccine Adverse Event Reporting System
31. Protective effect of breastfeeding upon first rotavirus infection and illness in a cohort of Mexican children
32. Simian rhesus rotavirus is a unique heterologous (non-lapine) rotavirus strain capable of productive replication and horizontal transmission in rabbits
33. Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus
34. Hypertrophy, hyperplasia, and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotaviruses
35. Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine
36. Kinetics, tissue specificity, and pathological changes in murine rotavirus infection of mice
37. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants
38. WC3 reassortant vaccines in children
39. Immune response of infants and children to low-passage bovine rotavirus (strain WC3)
40. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3
41. Evaluation of a bovine-human rotavirus reassortant vaccine in infants
42. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants
43. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12
44. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: A randomized placebo-controlled trial
45. Rotaviruses: Immunological determinants of protection against infection and disease
46. The rotavirus vaccine's withdrawal and physician's trust in vaccine safety mechanisms
47. The case for mumps vaccine